FDA Approves Crysvita for Victims of Tumor-Induced Osteomalacia
By Judy Ya-Hsuan Lin A number of patients globally suffer from excessive fibroblast growth factor 23 (FGF23). This rare disease causes tumors and induces a low phosphate concentration in the …
Read More